CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Clinical trial NCT03384589 · COMPLETED

Trial details

NCT number: NCT03384589
Sponsor: University of British Columbia
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Invasive Pneumococcal Disease, Protection Against Streptococcus Pneumoniae Infection

Start date: 2018-08-23
Primary completion: 2023-03-31
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.